Louis Calméjane

3PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 25, 2026
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Louis Calméjane, Catherine Reenaers, Claire Gay

|Jan 18, 2025
Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study.

Offir Ukashi, Aurelien Amiot, David Laharie

|Jul 21, 2023
Review article: Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies.

Louis Calméjane, David Laharie, Julien Kirchgesner

Pageof 1